Drugs News and Research

RSS

New research project seeks to understand how prostate cancer becomes resistant to radiotherapy

A new three year research project aimed at improving the effectiveness of radiotherapy treatment for men affected by prostate cancer is taking place at Queen's.

30 Jan 2012

Cell Therapeutics voluntarily withdraws Pixuvri NDA for NHL

Cell Therapeutics, Inc. announced today that it has voluntarily withdrawn its New Drug Application for Pixuvri (pixantrone) for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma in patients who failed two or more lines of prior therapy.

30 Jan 2012

Researchers describe malarial enzymes responsible for Vitamin B6 biosynthesis with atomic 3D structures

New research by scientists at the University of Southampton could lead to the design of more effective drugs to combat malaria.

30 Jan 2012

Inlyta receives FDA approval for treatment of advanced kidney cancer

The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.

30 Jan 2012

FTC terms Omnicare's proposed acquisition of PharMerica illegal

The Federal Trade Commission issued a complaint to block Omnicare, Inc.'s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others.

30 Jan 2012

Viewpoints: Health law's consumer safeguards; Shredding Medicare's safety net; Georgia's trauma crisis

Requiring the makers of drugs and medical devices to disclose most payments and gifts to physicians will protect patients and reduce medical costs. ... [the federal health law] requires the makers of drugs and medical devices to disclose most payments and gifts to physicians (1/27).

30 Jan 2012

Research roundup: Families in high deductible plans more likely to delay care; Cancer screening prevalence

Delayed And Forgone Care For Families With Chronic Conditions In High-Deductible Health Plans -- Researchers studied 208 families in high-deductible health plans (HDHPs) and 370 in traditional health plans who had children and at least one family member with a chronic condition.

30 Jan 2012

Hard drug users in 50s more likely to die earlier

Young adults often experiment with hard drugs, such as cocaine, amphetamines and opiates, and all but about 10 percent stop as they assume adult roles and responsibilities. Those still using hard drugs into their 50s are five times more likely to die earlier than those who do not, according to a new study by University of Alabama at Birmingham researchers published online Jan. 27, 2012, in the Journal of General Internal Medicine.

30 Jan 2012

Researchers develop new physical form of proteins to improve treatments for cancer

A new physical form of proteins developed by researchers at The University of Texas at Austin could drastically improve treatments for cancer and other diseases, as well as overcome some of the largest challenges in therapeutics: delivering drugs to patients safely, easily and more effectively.

30 Jan 2012

State roundup: Uninsured not the usual suspects in Texas, Calif.; Hopkins swanky new hospital; Georgia Medicaid

Nearly a quarter of the Texas population lacked health insurance in 2010, according to the most recent data released by the American Community Survey, which the U.S. Census Bureau conducted.

30 Jan 2012

Researchers study new strategies to treat patients with influenza

Influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and anti-viral drugs used to treat it. By first understanding the complex host cell pathways that the flu uses for replication, University of Georgia researchers are finding new strategies for therapies and vaccines, according to a study published in the January issue of the Journal of the Federation of American Societies for Experimental Biology.

30 Jan 2012

Susan Mallery finds breakthrough treatment for oral cancer

Dr. Susan Mallery, a professor in the College of Dentistry at The Ohio State University and Oral Pathology Consultant at the Ohio State University and James Cancer hospitals, has dedicated her nearly 30-year career to studying new strategies to preventing oral cancer.

30 Jan 2012

CDC publishes an in-depth analysis of Mogellons disease

Experts explain that Morgellons is not an official diagnosis but a syndrome of unexplained symptoms including abnormal sensations that sufferers describe as the feeling of insects crawling on the skin. Symptoms also include fatigue. And, perhaps most peculiarly, one symptom is tiny fibers found embedded in waxy scabs on the skin.

29 Jan 2012

New discovery paves way for genetic screening test

Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.

27 Jan 2012

Study explores links between antiretroviral prophylaxis, cleft lip and palate

HIV-positive mothers have been able to guard against transmitting the disease to their babies by taking antiretroviral drugs during pregnancy. Although the drugs prevent children from being born with HIV, they could cause birth defects, such as cleft lip and palate. A new study explores any links between antiretroviral prophylaxis and cleft lip and palate.

27 Jan 2012

State of the Union redux: Reading between the lines for health policy impact

News reports analyze why President Barack Obama gave only scant reference to the health law in his State of the Union address, how his push for regulatory reform may play out in the health care sector and how the speech represents his return to familiar themes.

27 Jan 2012

DWH signs collaboration agreement with CPDD

Developing World Health (DWH), a leading medical charity based in Stirlingshire, Scotland and committed to developing effective treatments for neglected tropical diseases, has signed a collaboration agreement with the internationally respected Consortium for Parasitic Drug Development (CPDD), based at The University of North Carolina at Chapel Hill.

27 Jan 2012

Cancer Research UK opens first AT9283 trial to treat childhood leukaemia

Cancer Research UK's Drug Development Office has opened the first trial of a new type of drug to treat children aged from six months to 18 years with acute leukaemia, who are no longer responding to treatment.

27 Jan 2012

Two NIH clinical trials to evaluate treatments for out-of-hospital cardiac arrest

The National Institutes of Health has launched two multi-site clinical trials to evaluate treatments for out-of-hospital cardiac arrest. One will compare continuous chest compressions (CCC) combined with pause- free rescue breathing to standard cardiopulmonary resuscitation (CPR), which includes a combination of chest compressions and pauses for rescue breathing.

27 Jan 2012

Rapid discontinuation of prednisone after kidney transplant can help prevent side effects

Rapid discontinuation of the immunosuppressive steroid prednisone after a kidney transplant can help prevent serious side effects, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

27 Jan 2012

Drugs News and Research

New research project seeks to understand how prostate cancer becomes resistant to radiotherapy

Cell Therapeutics voluntarily withdraws Pixuvri NDA for NHL

Researchers describe malarial enzymes responsible for Vitamin B6 biosynthesis with atomic 3D structures

Inlyta receives FDA approval for treatment of advanced kidney cancer

FTC terms Omnicare's proposed acquisition of PharMerica illegal

Viewpoints: Health law's consumer safeguards; Shredding Medicare's safety net; Georgia's trauma crisis

Research roundup: Families in high deductible plans more likely to delay care; Cancer screening prevalence

Hard drug users in 50s more likely to die earlier

Researchers develop new physical form of proteins to improve treatments for cancer

State roundup: Uninsured not the usual suspects in Texas, Calif.; Hopkins swanky new hospital; Georgia Medicaid

Researchers study new strategies to treat patients with influenza

Susan Mallery finds breakthrough treatment for oral cancer

CDC publishes an in-depth analysis of Mogellons disease

New discovery paves way for genetic screening test

Study explores links between antiretroviral prophylaxis, cleft lip and palate

State of the Union redux: Reading between the lines for health policy impact

DWH signs collaboration agreement with CPDD

Cancer Research UK opens first AT9283 trial to treat childhood leukaemia

Two NIH clinical trials to evaluate treatments for out-of-hospital cardiac arrest

Rapid discontinuation of prednisone after kidney transplant can help prevent side effects

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News